Stocklytics Platform
Asset logo for symbol GH
Guardant Health
GH56
$30.86arrow_drop_up1.54%$0.46
Asset logo for symbol GH
GH56

$30.86

arrow_drop_up1.54%
Key Stats
Open$30.26
Prev. Close$30.44
EPS-4.28
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range29.97
30.89
52 Week Range15.81
38.55
Ratios
EPS-4.28
Fundamentals
Debt/Equity Ratio-
Payout Ratio-
Industry average yield2.90%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

GH-
US Healthcare Sector-
US Market-
check_circle

GH / Market

GH exceeded the US Market which returned -0.55% over the last twenty four hours.
warning

GH / Healthcare Sector

GH lose to the US Healthcare sector which returned 2.04% over the last twenty four hours.

Guardant Health (GH) Statistics

Guardant Health Inc (GH) is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. From early cancer detection to treatment monitoring and assessing minimal residual disease, Guardant Health offers a comprehensive suite of solutions for cancer patients. Founded in 2012, the company has rapidly established itself as a pioneer in the liquid biopsy space, revolutionizing the way cancer is detected and monitored. Guardant Health's mission is to transform cancer care by enabling precision oncology across all stages of the disease.
When it comes to GH's stock statistics, it is important to note that as of the date of this writing, the stock is traded on the NASDAQ under the ticker symbol GH. GH's current valuation metrics indicate a promising outlook for investors. With a market capitalization of over $10 billion, GH has a substantial presence in the precision oncology market. The stock's fundamentals are also strong, with positive revenue growth and a healthy profit margin. Additionally, GH has a relatively low amount of total debt, which is favorable for long-term investors.
add Guardant Health  to watchlist

Keep an eye on Guardant Health

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Guardant Health (GH) stock's performance compared to its sector and the market over the past year?

Over the past year, Guardant Health (GH) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 23.94%, Guardant Health has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 45.94%, it has fallen short of the market average. This comparison highlights Guardant Health 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Guardant Health (GH) stock?

The PE ratio for Guardant Health (GH) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Guardant Health (GH) stock?

The Earnings Per Share (EPS) for Guardant Health (GH), calculated on a diluted basis, is -$4.28. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Guardant Health (GH) stock?

The operating margin for Guardant Health (GH) is -61.1%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Guardant Health (GH) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Guardant Health (GH) is -$386.31M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Guardant Health (GH) have?

Guardant Health (GH) has a total debt of $1.34B. The net debt, which accounts for cash and cash equivalents against the total debt, is $651.05M.

Take Your Investments to a Whole New Level